MedTrace Logo

Improving Drug Safety in Emergency Patients -a Randomized Controlled Trial

NCT03123640 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 806

Last updated 2023-02-21

No results posted yet for this study

Summary

Aim/Objective: Investigate the effect of implementing a working model for performing medication reconciliation (MR) and medication review (MRe) in the emergency department (ED), on readmissions, patient safety and efficiency of the stay in the ED and the hospital. Research design: randomized, controlled, non-blinded trial. Control group; standard care. Intervention group; MR and MRe performed at admission to the ED by a clinical pharmacist in the interdisciplinary team. The intervention is based on a working model for MR, developed in our initiation project, and it will be adapted to also include MRe. Key challenges in this research field: Currently no implemented systematic model ensuring that the patient's correct medication list is obtained and assessed at the point of admission. There is lack of studies investigating the clinically outcome of performing MR and MRe in the ED. Lack of knowledge on the extent of drug related hospital admissions in Norway. These challenges are also recognized and prioritized by the Norwegian authorities. Impact and utility: The results from this study will give important answers to the challenges listed above. The results could imply a huge impact on how to organize ED in Norway regarding drug safety. If the hypothesis of this study is confirmed, implementing the intervention described will increase patient safety, both the hospital and society can reduce health care expenses from readmissions, and also the readmission-burden can be reduced for the patients.

Conditions

  • Medication Compliance
  • Drug-Related Side Effects and Adverse Reactions
  • Remission
  • Medicinal Substance; Adverse Effect
  • Drug Interaction Potentiation

Interventions

OTHER

Medication reconciliation and medication review

Pharmacist performed medication reconciliation and medication review

Sponsors & Collaborators

  • Diakonhjemmet Hospital Pharmacy

    collaborator UNKNOWN

  • Diakonhjemmet Foundation

    collaborator UNKNOWN

  • University of Oslo

    collaborator OTHER

  • Diakonhjemmet Hospital

    lead OTHER

Principal Investigators

  • Erik H Øie, PhD, MD · Diakonhjemmet Hospital

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-24
Primary Completion
2018-05-16
Completion
2022-09-04

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03123640 on ClinicalTrials.gov